F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to provide chlordiazepoxide-clidinium (medication to help treat
stomach disorders) as ordered by a physician for one of three sampled residents (Resident 1) when the
medication was not administered two times a day for four days for treatment of Resident 1's gastritis
(inflammation of the lining of the stomach).
Residents Affected - Few
This failure had the potential for Resident 1 to experience weight loss due to lack of appetite caused by
abdominal pain.
Findings:
During a review of Resident 1 ' s admission Record(AR), the AR indicated, Resident 1 had diagnosis of
hypertension (high blood pressure in the vessels that carry blood from the heart to the rest of the body),
Parkinson's disease (brain disorder that causes unintended or uncontrollable movements such as shaking,
stiffness, and difficulty with balance and coordination), irritable bowel syndrome (a group of symptoms that
affect your digestive system with excessive gas, abdominal pain and cramps), gastro-esophageal reflux
(condition occurred by when stomach acid repeatedly flows back into the esophagus causing irritation) and
gastritis (inflammation of stomach). Resident 1 was admitted to the facility on [DATE] for rehabilitation after
C3 fracture (a break in the third cervical vertebra, which is part of spine in the neck).
During a review of Resident 1's Physician order (PO), dated 3/2022, the PO indicated, [Brand name]
chlordiazepoxide-clidinium capsule 5-2.5 MG (milligram-a unit of mass or weight equal to one thousandth of
a gram) two times a day for gastritis was ordered on 2/25/22 at 9:05 p.m.
During a review of Resident 1 ' s Medication Administration Record (MAR), dated [DATE], the MAR
indicated, chlordiazepoxide-clidinium was not administered as ordered on 2/26, 2/27 and 2/28.
During a review of Resident 1's MAR, dated March 2022, the MAR indicated, chlordiazepoxide-clidinium
was not given on 3/1/22. The MAR indicated, the first dose of [chlordiazepoxide-clidinium] was administered
on 3/2/22 at 4:30 p.m.
During a review of Resident 1's MD [Doctor of Medicine]/NP [nurse practitioner] /PA [physician assistant]
Progress Note dated 3/2/22 at 4:17 p.m., the MD/NP/PA Progress Note indicated, .[Resident 1] states that
she has not been getting the [chlordiazepoxide-clidinium]. Because she is not getting
[chlordiazepoxide-clidinium] she is having abd [abdominal] pain daily which causing her appetite to decline
.Will discuss her order [chlordiazepoxide-clidinium] with nursing staff .
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
056207
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056207
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/11/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Pacific Gardens Nursing and Rehabilitation Center
577 S. Peach Ave.
Fresno, CA 93727
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
During a phone interview on 2/28/23, at 3:50 p.m., with Licensed Vocational Nurse (LVN) 1, LVN 1 validated
the initials on Resident 1's MAR on 2/26/22, 2/27/22, 2/28/22 and 3/1/22 indicated,
chlordiazepoxide-clidinium was not administered. LVN 1 stated, [chlordiazepoxide-clidinium] was not
available to administer to Resident 1. LVN 1 stated the pharmacy did not send the medication. LVN 1
stated, she did not notify the physician or make any further efforts to determine why the medication was not
available. LVN 1 stated Resident 1 did not receive the prescribed medication for four days.
During an interview on 3/22/22, at 10:30 a.m., with the Director of Nursing (DON), the DON stated, Any
medication not given to [Resident 1] should have been entered in the MAR and the nurse should have
notified the MD [medical doctor].
During a review of the facility's policy and procedure (P&P) titled, Medication Shortages/Unavailable
Medications, dated 1/1/13, indicated, .If the medication is unavailable from Pharmacy, and cannot be
supplied from the manufacturer, Facility should obtain alternate Physician/Prescriber orders, as necessary .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056207
If continuation sheet
Page 2 of 2